Interactions between corticosteroids and β-adrenergic agonists in asthma disease induction, progression, and exacerbation

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 3 II, 2000, Pages

  Anderson, Gary P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CORTICOSTEROID RECEPTOR;

ASTHMA; CONFERENCE PAPER; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG USE; HUMAN; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0034069055     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_2.a1q4-9     Document Type: Conference Paper

References (85)

1. Haahtela, T., M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, and A. Sovijarvi. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
2. Greening, A. P., P. W. Ind, M. Northfield, and G. Shaw. 1994. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:219-224.
3. Woolcock, A., B. Lundback, N. Ringdal, and L. A. Jacques. 1996. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 153:1481-1488.
4. Pauwels, R. A., C. G. Lofdahl, D. S. Postma, A. E. Tattersfield, P. O'Byrne, P. J. Barnes, and A. Ullman. 1997. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:1405-1411.
5. Taylor, D. R., G. I. Town, G. P. Herbison, D. Boothman-Burrell, E. M. Flannery, B. Hancox, E. Harre, K. Laubscher, V. Linscott, C. M. Ramsay, and G. Richards. 1998. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 53:744-752.
6. Chervinsky, P., P. Goldberg, S. Galant, Y. Wang, T. Arledge, M. B. Welch, and E. Stahl. 1999. Long-term cardiovascular safety of salmeterol powder pharmacothcrapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trial. Chest 115:642-648.
7. Verberne, A. A., C. Frost, R. J. Roorda, H. van der Laag, and K. F. Kerrebijn. 1997. One year treatment with salmeterol compared with beclomethasone in children with asthma: The Dutch Paediatric Asthma Study Group. Am. J. Respir. Crit. Care Med. 156:688-695.
8. Vervloet, D., T. Ekstrom, R. Pela, F. Duce Gracia, C. Kopp, B. D. Silvert, E. Quebe-Fehling, G. Della Cioppa, and G. Di Benedetto. 1998. A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease. Respir. Med. 92:836-842.
9. Carstairs, J. R., A. J. Nimmo, and P. J. Barnes. 1985. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am. Rev. Respir. Dis. 132:541-547.
10. Kaumann, A. J., F. Preitner, D. Sarsero, P. Molenaar, J. P. Revelli, and J. P. Giacobino. 1998. (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol. Pharmacol. 53:670-675.
11. Isogaya, M., Y. Yamagiwa, S. Fujita, Y. Sugimoto, T. Nagao, and H. Kurose. 1998. Identification of a key amino acid of the beta2-adrenergic receptor for high affinity binding of salmeterol. Mol. Pharmacol. 54:616-622.
12. Anderson, G. P., A. Linden, and K. F. Rabe. 1994. Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J. 7:569-578.
13. Small, R. C., P. Chui, S. J. Cook, R. W. Foster, and L. Isaac. 1993. Beta adrenoceptor agonists in bronchial asthma: role of K+ channel opening in mediating their bronchodilator effects. Clin. Exp. Allergy 23:802-811.
14. Molimard, M., E. Naline, Y. Zhang, V. Le Gros, B. Beguad, and C. Advenier. 1998. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi. Eur. Respir. J. 11:583-588.
15. Clark, R. B., C. Allal, J. Friedman, M. Johnson, and R. Barber. 1996. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. Mol. Pharmacol. 49:182-189.
16. Roux, F. J., B. Grandordy, and J. S. Douglas. 1996. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart. Am. J. Respir. Crit. Care Med. 153:1489-1495.
17. Munoz, N. M., K. F. Rabe, A. J. Vita, K. McAllister, D. Mayer, M. Weiss, and A. R. Leff. 1995. Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol. J. Pharmacol. Exp. Ther. 273:850-854.
18. Teschemacher, A., and H. Lemoine. 1999. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase. J. Pharmacol. Exp. Ther. 288:1084-1092.
19. Green, S. A., A. P. Spasoff, R. A. Coleman, M. Johnson, and S. B. Liggett. 1996. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding: molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J. Biol. Chem. 271:24029-24035.
20. Waldeck, B. 1999. Enantiomers of bronchodilating beta2-adrenoceptor agonists: is there a cause for concern? J. Allergy Clin. Immunol. 103: 742-748.
21. Mitra, S., M. Ugur, O. Ugur, H. M. Goodman, J. R. McCullough, and H. Yamaguchi. 1998. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol. Pharmacol. 53:347-354.
22. Vachier, I., G. Chiappara, A. M. Vignola, R. Gagliardo, E. Altieri, B. Terouanne, P. Vic, J. Bousquet, P. Godard, and P. Chanez. 1998. Glucocorticoid receptors in bronchial epithelial cells in asthma. Am. J. Respir. Crit. Care Med. 158:963-970.
23. Gronemeyer, H. 1993. Nuclear hormone receptors as transcriptional activators. In M. G. Parker, editor. Steroid Hormone Action. IRL Press, New York. 93-117.
24. Yang-Yen, H. F., J. C. Chambard, Y. L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
25. Koenig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241-2246.
26. Diamond, M. I., J. N. Miner, S. K. Yoshinaga, and K. R. Yamamoto. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272.
27. Baeuerle, P. A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242:540-546.
28. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 91:752-756.
29. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
30. Kujubu, D. A., and H. R. Herschman. 1992. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267:7991-7994.
31. Wolffe, A. P., J. Wong, Q. Li, B. Z. Levi, and Y. B. Shi. 1997. Three steps in the regulation of transcription by the thyroid hormone receptor: establishment of a repressive chromatin structure, disruption of chromatin and transcriptional activation. Biochem. Soc. Trans. 25:612-615.
32. Beato, M., S. Chavez, and M. Truss. 1996. Transcriptional regulation by steroid hormones. Steroids 61:240-251.
33. Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45-51.
34. Lee, S. W., A. P. Tsou, H. Chan, J. Thomas, K. Petrie, E. M. Eugui, and A. C. Allison. 1988. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc. Natl. Acad. Sci. U.S.A. 85:1204-1208.
35. Coyle, A. J., G. Le Gros, C. Bertrand, S. Tsuyuki, C. H. Heusser, M. Kopf, and G. P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54-59.
36. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527-1536.
37. Bruselle, G. G., J. C. Kips, R. A. Peleman, G. F. Joos, R. R. Devos, J. H. Tavernier, and R. A. Pauwels. 1997. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am. J. Respir. Cell Mol. Biol. 17:767-771.
38. Hasko, G., C. Szabo, Z. H. Nemeth, A. L. Salzman, and E. S. Vizi. 1998. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmunol. 88: 57-61.
39. Panina-Bordignon, P., D. Mazzeo, P. D. Lucia, D. D'Ambrosio, R. Lang, L. Fabbri, C. Self, and F. Sinigaglia. 1997. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1513-1519.
40. Gibbs, B. F., I. B. Vollrath, C. Albrecht, U. Amon, and H. H. Wolff. 1998. Inhibition of interleukin-4 and interleukin-13 release from immunologically activated human basophils due to the actions of anti-allergic drugs. Naunyn Schmiedeberg's Arch. Pharmacol. 357:573-578.
41. Chong, L. K., E. Cooper, C. J. Vardey, and P. T. Peachell. 1998. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Br. J. Pharmacol. 123:1009-1015.
42. Taylor, D. A., M. W. Jensen, S. L. Aikman, J. G. Harris, P. J. Barnes, and B. J. O'Connor. 1997. Comparison of salmeterol and albuterol-induced: bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am. J. Respir. Crit. Care Med. 156:1731-1737.
43. Anderson, G. P., and A. J. Coyle. 1994. "TH2-like" cells in allergy and asthma: pharmacological and perspectives. Trends Pharmacol. Sci. 15: 324-332.
44. Nelson, D. J., A. S. McWilliam, S. Haining, and P. G. Holt. 1995. Modulation of airway intraepithelial dendritic cells following exposure to steroids. Am. J. Respir. Crit. Care Med. 151:475-481.
45. Brokaw, J. J., G. W. White, P. Baluk, G. P. Anderson, E. Y. Umemoto, and D. M. McDonald. 1998. Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am. J. Respir. Cell Mol. Biol. 19:598-605.
46. Holen, E., and S. Elsayed. 1998. Effects of beta2 adrenoceptor agonists on T-cell subpopulations. APMIS 106:849-857.
47. Bloemen, P. G., M. C. van den Tweel, P. A. Henricks, F. Engels, M. H. Kester, P. G. van de Loo, F. J. Blomjous, and F. P. Nijkamp. 1997. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am. J. Physiol. 272:L580-L587.
48. Penn, R. B., J. R. Shaver, J. G. Zangrilli, M. Pollice, J. E. Fish, S. P. Peters, and J. L. Benovic. 1996. Effects of inflammation and acute beta-agonist inhalation on beta 2-AR signalling in human airways. Am. J. Physiol. 271:L601-L608.
49. Gormand, F., S. Cheria-Sammari, R. Aloui, B. Guibert, D. Malicier, M. Perrin-Fayolle, M. Lagarde, and Y. Pacheco. 1995. Granulocyte-macrophage colony stimulating factors (GM-CSF) and interleukin 8 (IL-8) production by human bronchial epithelial cells (HBEC) in asthmatics and controls: lack of in vitro effect of salbutamol compared to nedocromil. Pulm. Pharmacol. 8:107-113.
50. Marrack, P., J. Kappler, and T. Mitchell. 1998. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-530.
51. NIH. 1999. SOCS/SLIC trial.
52. Lambrecht, B. N., B. Salomon, D. Klatzmann, and R. A. Pauwels. 1998. Dendritic cells are required for the development of chronic cosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J. Immunol. 160:4090-4097.
53. Dabbagh, K., K. Takeyama, H. M. Lee, I. F. Ueki, J. A. Lausier, and J. A. Nadel. 1999. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 162:6233-6237.
54. Blyth, D. I., M. S. Pedrick, T. J. Savage, H. Bright, J. E. Beesley, and S. Sanjar. 1998. Induction, duration, and resolution of airway goblet cell hyperplasia in a murinc model of atopic asthma: effect of concurrent infection with respiratory syncytial virus and response to dexamethasone. Am. J. Respir. Cell Mol. Biol. 19:38-54.
55. Stewart, A. G., P. R. Tomlinson, and J. W. Wilson. 1997. Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br. J. Pharmacol. 121:361-368.
56. Vlahos, R., and A. G. Stewart. 1999. Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate. Br. J. Pharmacol. 126:1315-1324.
57. Bai, T. R., J. C. Mak, and P. J. Barnes. 1992. A comparison of β-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 6:647-651.
58. Kawahara, R. S., Z. W. Deng, and T. F. Deuel. 1991. Glucocorticoids inhibit the transcriptional induction of JE, a platelet-derived growth factor-inducible gene. J. Biol. Chem. 266:13261-13266.
59. Coulter, K. R., M. D. Wewers, M. P. Lowe, and D. L. Knoell. 1999. Extracellular regulation of interleukin (IL)-1β through lung epithelial cells and defective IL-1 type II receptor expression. Am. J. Respir. Cell Mol. Biol. 20:964-975.
60. Dowling, R. B., M. Johnson, P. J. Cole, and R. Wilson. 1998. Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. Eur. Respir. J. 11:86-90.
61. Dowling, R. B., C. F. Rayner, A. Rutman, A. D. Jackson, K. Kanthakumar, A. Dewar, G. W. Taylor, P. J. Cole, M. Johnson, and R. Wilson. 1997. Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am. J. Respir. Crit. Care Med. 155:327-336.
62. Turner, M. O., P. R. Johnston, E. Pizzichini, M. M. Pizzichini, P. A. Hussack, and F. E. Hargreave. 1998. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial. Can. Respir. J. 5:261-268.
63. McIvor, R. A., E. Pizzichini, M. O. Turner, P. Hussack, F. E. Hargreave, and M. R. Sears. 1998. Potential masking effects of salmeterol on airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 158:924-930.
64. 2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am. J. Respir. Crit. Care Med. 158:787-791.
65. Bai, T. R. 1990. Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 141:552-557.
66. Bai, T. R. 1991. Abnormalities in airway smooth muscle in fatal asthma: a comparison between trachea and bronchus. Am. Rev. Respir. Dis. 143:441-443.
67. Cerione, R. A., J. Codina, J. L. Benovic, R. J. Lefkowitz, L. Birnbaumer, and M. G. Caron. 1984. The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. Biochemistry 23:4519-4525.
68. Samama, P., S. Cotecchia, T. Costa, and R. J. Lefkowitz. 1993. A mutation-induced activated state of the beta 2 adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:4625-4636.
69. Wills-Karp, M., Y. Uchida, J. Y. Lee, J. Jinot, A. Hirata, and F. Hirata. 1993. Organ culture with proinflammatory cytokines reproduces impairment of the β-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am. J. Respir. Cell Mol. Biol. 8:153-159.
70. Van Amsterdam, R. G., H. Meurs, R. E. Ten Berge, N. C. Veninga, F. Brouwer, and J. Zaagsma. 1990. Role of phosphoinositide metabolism in human bronchial smooth muscle contraction and in functional antagonism by β-adrenoceptor agonists. Am. Rev. Respir. Dis. 142:1124-1128.
71. Chilvers, E. R., B. J. Lynch, and R. A. Challiss. 1997. Dissociation between beta-adrenoceptor-mediated cyclic AMP accumulation and inhibition of histamine-stimulated phosphoinositide metabolism in airways smooth muscle. Biochem. Pharmacol. 53:1565-1568.
72. Lemoine, H., and C. Overlack. 1992. Highly potent beta-2 sympathomimetics convert to less potent partial agonists as relaxants of guinea pig tracheae maximally contracted by carbachol: comparison of relaxation with receptor binding and adenylate cyclase stimulation. J. Pharmacol. Exp. Ther. 261:258-270.
73. January, B., A. Seibold, C. Allal, B. S. Whaley, B. J. Knoll, R. H. Moore, B. F. Dickey, R. Barber, and R. B. Clark. 1998. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br. J. Pharmacol. 123:701-711.
74. Hauck, R. W., M. Harth, C. Schulz, H. Prauer, M. Bohm, and A. Schomig. 1997. Effects of beta 2-agonist-and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue. Br. J. Pharmacol. 121:1523-1530.
75. Lipworth, B. J., and I. Aziz. 1999. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. J. Allergy Clin. Immunol. 103: 88-92.
76. Tan, K. S., A. Grove, A. McLean, Y. Gnosspelius, I. P. Hall, and B. J. Lipworth. 1997. Systemic corticosteroid rapidly reverses bronchodilatory subsensitivity induced by regular formoterol. Am. J. Respir. Crit. Care Med. 156:28-35.
77. Boulet, L. P., A. Cartier, J. Milot, J. Cote, J. L. Malo, and M. Laviolette. 1998. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. Eur. Respir. J. 11:1091-1097.
78. Giannini, D., E. Bacci, F. L. Dente, A. Di Franco, B. Vagaggini, R. Testi, and P. Paggiaro. 1999. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge. Chest 115:629-634.
79. Eickelberg, O., M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L. H. Block. 1999. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J. Biol. Chem. 274: 1005-1010.
80. Orti, E., L. M. Hu, and A. Munck. 1993. Kinetics of glucocorticoid receptor phosphorylation in intact cells: evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J. Biol. Chem. 268:7779-7784.
81. Ning, Y. M., and E. R. Sanchez. 1995. Evidence for a functional interaction between calmodulin and the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 208:48-54.
82. Migliaccio, A., A. Rontondi, and F. Auricchio. 1984. Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine. Proc. Natl. Acad. Sci. U.S.A. 81:5921-5925.
83. Peters, M. J., I. M. Adcock, C. R. Brown, and P. J. Barnes. 1995. Beta-adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur. J. Pharmacol. 289:275-281.
84. Oddera, S., M. Silvestri, R. Testi, and G. A. Rossi. 1998. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation. Respiration 65:199-204.
85. Seldon, P. M., D. A. Stevens, I. M. Adcock, B. J. O'Connor, P. J. Barnes, and M. A. Giembycz. 1998. Albuterol does not antagonize the inhibitory effect of dexamethasone on monocyte cytokine release. Am. J. Respir. Crit. Care Med. 157:803-809.